Breaking News

Covance Unveils New R&D Center in Shanghai

Doubles capacity for clinical development and commercialization, bioanalytical and central laboratory services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

LabCorp’s Covance Drug Development business celebrated the opening of its new R&D Center in Shanghai, China, which is now its largest facility in the Asia Pacific region.   “We entered China in 1998 and have grown our breadth of services, scientific capabilities and therapeutic expertise progressively, building our operations to meet global standards and requirements,” said John Ratliff, chief executive officer, Covance. “Today we are the only provider to offer comprehensive R&D servic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters